Evolution of the Average Target: IBEX Limited

Evolution of the Target Price: IBEX Limited

Changes in Analyst Recommendations: IBEX Limited

1.oE93aCJPm3oAH_P4D-4P_-k7A6mJKhC0pJ_wEwkGcOs._3kTXW5iriB0SpePathBrdp1a8TiSVzfz6aERjtXNoz3LgJfQSHuNVZIvg~a63e43a80d566dfc5d97aa108f30b938
11-10 RBC Lifts Price Target on IBEX to $40 From $39, Keeps Sector Perform Rating MT
12/09/25 IBEX Rallies to All-Time High Following Higher Fiscal Q4 Results MT
12/09/25 Ibex Q4 Beat Driven by Revenue Acceleration, GenAI Adoption, RBC Says MT
12/09/25 RBC Raises Price Target on IBEX to $39 From $31, Keeps Sector Perform Rating MT
12/05/25 Baird Downgrades IBEX to Neutral From Outperform, $30 Price Target MT
07/02/25 RBC Capital Adjusts Price Target on IBEX to $24 From $21, Keeps Sector Perform Rating MT
13/09/24 RBC Raises Price Target on IBEX to $20 From $18, Keeps Sector Perform Rating MT
19/04/24 Baird Adjusts Price Target on IBEX to $20 From $21, Maintains Outperform Rating MT
10/11/23 RBC Lifts Price Target on IBEX to $19 From $18, Keeps Sector Perform Rating MT
10/11/23 Piper Sandler Downgrades IBEX to Neutral From Overweight, Price Target is $17 MT
28/09/23 Baird Adjusts Price Target on IBEX to $22 From $24, Keeps Outperform Rating MT
18/09/23 Piper Sandler Cuts Price Target on IBEX to $17 From $24, Keeps Overweight Rating MT
14/09/23 Citigroup Adjusts Price Target on IBEX to $18 From $23, Maintains Neutral Rating MT
14/09/23 Baird Adjusts Price Target on IBEX to $24 From $28, Maintains Outperform Rating MT
14/09/23 Truist Securities Adjusts IBEX Price Target to $25 From $32, Maintains Buy Rating MT
14/09/23 IBEX Downgraded by RBC to Sector Perform From Outperform, Price Target Cut to $18 From $27 MT
19/05/23 Piper Sandler Adjusts Price Target on IBEX to $24 From $32, Keeps Overweight Rating MT
18/05/23 Citigroup Adjusts Price Target on IBEX to $23 From $30, Keeps Neutral Rating MT
18/05/23 RBC Cuts Price Target on IBEX to $27 From $30, Citing 'Revenue Growth Pressures,' Decline in Peer Valuations; Outperform Rating Kept MT
18/05/23 Baird Adjusts IBEX Price Target to $28 From $32, Maintains Outperform Rating MT
16/02/23 RBC Raises Price Target on IBEX to $30 From $26, Maintains Outperform Rating MT
06/01/23 Piper Sandler Adjusts Price Target on IBEX to $29 From $27, Maintains Overweight Rating MT
18/11/22 Citigroup Raises Price Target on IBEX to $26 From $18, Maintains Neutral Rating MT
16/11/22 Truist Securities Adjusts IBEX Price Target to $27 From $22, Maintains Buy Rating MT
16/11/22 Piper Sandler Adjusts Price Target on IBEX to $27 From $20, Maintains Overweight Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- - +4.2%
-0.28%
+77.01%
+21.24%
-16.8%
+12%
+12.65%
+58.36%
- +14.67%
+63.26%
Average +24.63%
Weighted average by Cap. +26.01%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
35.99USD
Average target price
37.50USD
Spread / Average Target
+4.20%
High Price Target
40.00USD
Spread / Highest target
+11.14%
Low Price Target
35.00USD
Spread / Lowest Target
-2.75%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

RBC Capital Markets
Baird
Piper Sandler
Citigroup
Truist Securities
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
35.99USD
Average target price
37.50USD
Spread / Average Target
+4.20%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IBEX Stock
  4. Consensus IBEX Limited